Are there differences between radiological changes and two acute phase proteins in patients with pulmonary tuberculosis? Source: Eur Respir J 2002; 20: Suppl. 38, 442s Year: 2002
Acute phase reaction in pulmonary tuberculosis during treatment Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients Source: International Congress 2018 – New developments in tuberculosis Year: 2018
Relation of D-dimer levels and extent of disease in patients with active tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
The Importance of the local expression of acute phase reactants in the COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002
Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The dynamics of reactants of acute phase of inflammation in adolescents with newly detected drug-resistant TB during the treatment Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Acute phase reaction in patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 646s Year: 2004
The use of symbicort in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 85s Year: 2007
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020
The value of positive acute phase proteins in differential diagnosis of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 341s Year: 2003
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012